Strongbridge Biopharma PLC Company Profile (NASDAQ:SBBP)

About Strongbridge Biopharma PLC

Strongbridge Biopharma PLC logoStrongbridge Biopharma plc, formerly Cortendo plc, is a development-stage biopharmaceutical company. The Company is engaged in advancing its product candidates through clinical development. The Company is focused on the development, in-licensing, acquisition and eventual commercialization of several complementary products and product candidates within franchises that target rare diseases. Its principal focus is to build its rare endocrine franchise, which includes product candidates for the treatment of endogenous Cushing's syndrome and acromegaly. Its product candidate, COR-003 (levoketoconazole), is a cortisol synthesis inhibitor, indicated for the treatment of endogenous Cushing's syndrome. It is conducting SONICS, a pivotal Phase III clinical trial for COR-003. Its product candidate, COR-005 (veldotide), is a multi-receptor targeted somatostatin analog (SSA) in Phase II clinical development for the treatment of acromegaly patients. Its product candidate also includes BP-2002.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SBBP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.60
  • 50 Day Moving Average: $2.42
  • 200 Day Moving Average: $3.88
  • 52-Week Range: $2.00 - $6.39
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.32
  • P/E Growth: 0.00
  • Market Cap: $55.13M
  • Outstanding Shares: 21,205,000
  • Beta: 2.75
Profitability:
  • Return on Equity: -50.52%
  • Return on Assets: -47.00%
Debt:
  • Current Ratio: 6.08%
  • Quick Ratio: 6.08%
Additional Links:
Companies Related to Strongbridge Biopharma PLC:

Analyst Ratings

Consensus Ratings for Strongbridge Biopharma PLC (NASDAQ:SBBP) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (438.46% upside)

Analysts' Ratings History for Strongbridge Biopharma PLC (NASDAQ:SBBP)
Show:
DateFirmActionRatingPrice TargetDetails
1/25/2017HC WainwrightBoost Price TargetBuy$15.00 -> $18.00View Rating Details
12/28/2016JMP SecuritiesReiterated RatingOutperform$10.00View Rating Details
2/3/2016Roth CapitalInitiated CoverageBuy$12.00View Rating Details
12/10/2015Janney Montgomery ScottInitiated CoverageBuy$19.00View Rating Details
12/7/2015Stifel NicolausReiterated RatingBuyView Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Strongbridge Biopharma PLC (NASDAQ:SBBP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/2016        
5/17/2016Q1($0.63)($0.57)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Strongbridge Biopharma PLC (NASDAQ:SBBP)
Current Year EPS Consensus Estimate: $-1.83 EPS
Next Year EPS Consensus Estimate: $-1.12 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.31)($0.31)($0.31)
Q2 20161($0.51)($0.51)($0.51)
Q3 20161($0.47)($0.47)($0.47)
Q4 20161($0.38)($0.38)($0.38)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Strongbridge Biopharma PLC (NASDAQ:SBBP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Strongbridge Biopharma PLC (NASDAQ:SBBP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Strongbridge Biopharma PLC (NASDAQ:SBBP)
DateHeadline
finance.yahoo.com logoStrongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day (NASDAQ:SBBP)
finance.yahoo.com - February 3 at 3:38 AM
finance.yahoo.com logoStrongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires (NASDAQ:SBBP)
finance.yahoo.com - January 9 at 9:08 AM
publicnow.com logoStrongbridge Biopharma plc to Present at Biotech Showcase 2017 (NASDAQ:SBBP)
www.publicnow.com - January 5 at 6:20 AM
investingnews.com logoStrongbridge Biopharma Announces Closing of $35 Million Equity Financing and $40 Million Credit Facility (NASDAQ:SBBP)
investingnews.com - December 30 at 12:39 AM
publicnow.com logoStrongbridge Biopharma plc Announces Closing of $35 Million Equity Financing and $40 Million Credit Facility (NASDAQ:SBBP)
us.rd.yahoo.com - December 29 at 7:38 PM
fxpips.com logoComposite Trading’s 20 Leading Percentage Losing Stocks (NASDAQ:SBBP)
www.fxpips.com - December 29 at 12:34 AM
marketexclusive.com logoAnalyst Activity – JMP Securities Reiterates Outperform on Strongbridge Biopharma (NASDAQ:SBBP) (NASDAQ:SBBP)
marketexclusive.com - December 29 at 12:34 AM
us.rd.yahoo.com logo8:01 am Strongbridge Biopharma (thinly traded) enters into a securities purchase agreement for a placement of 14 mln of its ordinary shares priced at $2.50/share & warrants to purchase 7 mln shares for gross proceeds of $35 mln (NASDAQ:SBBP)
us.rd.yahoo.com - December 23 at 7:49 PM
publicnow.com logoStrongbridge Biopharma plc Provides Corporate and Financial Update (NASDAQ:SBBP)
www.publicnow.com - December 23 at 7:49 PM
publicnow.com logoStrongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro (NASDAQ:SBBP)
www.publicnow.com - December 23 at 7:49 PM
publicnow.com logoStrongbridge Biopharma plc Announces $35 Million Equity Financing (NASDAQ:SBBP)
www.publicnow.com - December 23 at 7:49 PM
marketwatch.com logoStonebridge Biopharma raises $35 million by selling shares at a deep discount (NASDAQ:SBBP)
www.marketwatch.com - December 23 at 7:49 PM
bizjournals.com logo$35M infusion: Bucks County biopharm firm reaches funding deal (NASDAQ:SBBP)
www.bizjournals.com - December 23 at 7:49 PM
News IconJust Published: "Strongbridge Biopharma plc (SBBP) - Financial and Strategic SWOT Analysis Review" (NASDAQ:SBBP)
reports.pr-inside.com - November 30 at 10:55 AM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Promotion of Fredric Cohen, M.D., to Chief Medical Officer (NASDAQ:SBBP)
finance.yahoo.com - November 29 at 3:14 PM
News IconStrongbridge Biopharma plc SBBP Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:SBBP)
www.bioportfolio.com - November 24 at 7:19 PM
News IconStrongbridge Biopharma plc SBBP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:SBBP)
www.bioportfolio.com - November 16 at 11:00 AM
publicnow.com logoStrongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors (NASDAQ:SBBP)
www.publicnow.com - October 3 at 11:49 AM
finance.yahoo.com logoStrongbridge Biopharma (SBBP) Jumps: Stock Moves Up 5.5% (NASDAQ:SBBP)
finance.yahoo.com - August 11 at 10:33 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - July 6 at 7:51 AM
fxpips.com logoBig Moving Stocks Highlights Today – CCCL, RLOC, XNCR, CLWT, FUEL, ENDP, RNET (NASDAQ:SBBP)
www.fxpips.com - June 29 at 10:00 AM
publicnow.com logoStrongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London (NASDAQ:SBBP)
www.publicnow.com - June 14 at 7:59 AM
publicnow.com logoStrongbridge Biopharma plc Announces Executive Promotion and Leadership Transition (NASDAQ:SBBP)
www.publicnow.com - June 9 at 4:39 PM
capitalcube.com logoStrongbridge Biopharma Plc :SBBP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:SBBP)
www.capitalcube.com - June 8 at 6:08 PM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - June 2 at 4:15 PM
publicnow.com logoEY Announces Strongbridge Biopharma's President and CEO Matthew Pauls is Named an EY Entrepreneur Of The Year® 2016 Finalist in Greater Philadelphia (NASDAQ:SBBP)
www.publicnow.com - June 2 at 8:25 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology (NASDAQ:SBBP)
www.publicnow.com - May 31 at 7:52 AM
publicnow.com logoStrongbridge Biopharma plc Reports First Quarter 2016 Financial Results (NASDAQ:SBBP)
www.publicnow.com - May 17 at 8:52 AM
sg.finance.yahoo.com logoStrongbridge Biopharma reports 1Q loss (NASDAQ:SBBP)
sg.finance.yahoo.com - May 17 at 8:42 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at Bio€quity Europe 2016 (NASDAQ:SBBP)
www.publicnow.com - May 5 at 9:21 AM
finance.yahoo.com logoCoverage initiated on Strongbridge Biopharma by H.C. Wainwright (NASDAQ:SBBP)
finance.yahoo.com - April 25 at 7:09 AM
fxpips.com logoWhat’s Buzzing: Stock Gaps Up – LBTYB, SBBP, KOOL, LEU, CSTE, HLX, FOLD, HPJ, CHK, OBCI (NASDAQ:SBBP)
www.fxpips.com - April 13 at 10:55 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation at 15th Annual Needham Healthcare Conference (NASDAQ:SBBP)
www.publicnow.com - April 6 at 7:50 AM
fxpips.com logoThese Wall Street Stocks are Gapping Up today… (NASDAQ:SBBP)
www.fxpips.com - April 4 at 10:23 AM
thestreet.com logoStrongbridge Biopharma Plc Announces Presentation Of COR-003 Data At The Endocrine Society's 2016 Annual Conference (NASDAQ:SBBP)
www.thestreet.com - April 4 at 10:23 AM
publicnow.com logoStrongbridge Biopharma plc Announces Presentation of COR-003 Data at the Endocrine Society’s 2016 Annual Conference (NASDAQ:SBBP)
www.publicnow.com - April 4 at 7:57 AM
finance.yahoo.com logoSTRONGBRIDGE BIOPHARMA PLC Financials (NASDAQ:SBBP)
finance.yahoo.com - March 30 at 1:04 PM
publicnow.com logoStrongbridge Biopharma plc Reports Full-Year 2015 Financial Results (NASDAQ:SBBP)
www.publicnow.com - March 24 at 7:56 AM
fxpips.com logoStocks Making Gaps Up today – FORK, STAF, SBBP, PNRG, SMLR, TGEN, DRIO (NASDAQ:SBBP)
www.fxpips.com - March 22 at 10:15 AM
fxpips.com logoActive Stocks Rising – SBBP, URRE, XNCR, THO, UNFI, OMER, LEU, SCTY, URBN, SUNE (NASDAQ:SBBP)
www.fxpips.com - March 10 at 9:52 AM
fxpips.com logoBiggest Moving Stocks, March 9 – URRE, OMER, OTEL, URBN, SBBP, SCTY, AMSC, EPIX, TERP (NASDAQ:SBBP)
www.fxpips.com - March 9 at 9:39 AM
bizjournals.com logoBucks biopharm firm returns one drug candidate, stops development of another (NASDAQ:SBBP)
www.bizjournals.com - March 7 at 10:55 AM
finance.yahoo.com logo7:33 am Strongbridge Biopharma provides update on corporate progress; co initiates the return of COR-004 to Antisense Therapeutics and will not invest further in the development of BP-2002 (NASDAQ:SBBP)
finance.yahoo.com - March 7 at 7:33 AM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences (NASDAQ:SBBP)
finance.yahoo.com - February 25 at 7:30 AM
fxpips.com logoTraders Pick These Stocks Today – Strongbridge (SBBP), Aclaris (ACRS), Check-Cap (CHEK) (NASDAQ:SBBP)
www.fxpips.com - February 24 at 9:31 AM
fxpips.com logoManufacturing Sector’s Top Gainers and Losers, Feb. 22 (NASDAQ:SBBP)
www.fxpips.com - February 22 at 8:57 AM
finance.yahoo.com logoStrongbridge Biopharma Announces Annual General Meeting of Shareholders (NASDAQ:SBBP)
finance.yahoo.com - February 18 at 4:05 PM
finance.yahoo.com logoStrongbridge Biopharma plc Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day (NASDAQ:SBBP)
finance.yahoo.com - February 18 at 7:30 AM
finance.yahoo.com logoStrongbridge Biopharma plc (SBBP) (NASDAQ:SBBP)
finance.yahoo.com - January 24 at 8:45 AM
finance.yahoo.com logoMast Therapeutics Announces Appointment Of Matthew Pauls To Board Of Directors (NASDAQ:SBBP)
finance.yahoo.com - November 2 at 8:00 AM

Social

What is Strongbridge Biopharma PLC's stock symbol?

Strongbridge Biopharma PLC trades on the NASDAQ under the ticker symbol "SBBP."

Where is Strongbridge Biopharma PLC's stock going? Where will Strongbridge Biopharma PLC's stock price be in 2017?

2 brokerages have issued 1-year target prices for Strongbridge Biopharma PLC's shares. Their forecasts range from $10.00 to $18.00. On average, they anticipate Strongbridge Biopharma PLC's stock price to reach $14.00 in the next twelve months.

When will Strongbridge Biopharma PLC announce their earnings?

Strongbridge Biopharma PLC is scheduled to release their next quarterly earnings announcement on Tuesday, May, 17th 2016.

Who owns Strongbridge Biopharma PLC stock?

Strongbridge Biopharma PLC's stock is owned by many different of retail and institutional investors. Top institutional investors include Vivo Capital LLC (14.15%), Broadfin Capital LLC (13.65%), Boxer Capital LLC (4.43%) and Tredje AP fonden (4.29%).

Who bought Strongbridge Biopharma PLC stock? Who is buying Strongbridge Biopharma PLC stock?

Strongbridge Biopharma PLC's stock was bought by a variety of institutional investors in the last quarter, including Vivo Capital LLC, Broadfin Capital LLC and Boxer Capital LLC.

How do I buy Strongbridge Biopharma PLC stock?

Shares of Strongbridge Biopharma PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Strongbridge Biopharma PLC stock cost?

One share of Strongbridge Biopharma PLC stock can currently be purchased for approximately $2.60.

Strongbridge Biopharma PLC (NASDAQ:SBBP) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Strongbridge Biopharma PLC (NASDAQ:SBBP)

Earnings History Chart

Earnings by Quarter for Strongbridge Biopharma PLC (NASDAQ:SBBP)

Dividend History Chart

Dividend Payments by Quarter for Strongbridge Biopharma PLC (NASDAQ:SBBP)

Last Updated on 2/21/2017 by MarketBeat.com Staff